Analyst Is Positive on BDMS Increasing Foreign Limit, Eyeing Target Price at THB34.10

Kasikorn Securities (KS) has a positive view on Bangkok Dusit Medical Services Public Company Limited (SET: BDMS) regarding the increase of its foreign limit. 

The Board of Directors yesterday approved BDMS to increase its foreign limit to 30% from 25% to increase liquidity of the company. Currently, foreign investors have already pushed the ownership close to the limit. 

The resolution will require an approval of shareholders on September 6, 2023. 

KS is positive on the decision, which will increase foreign shareholders that have voting rights unlike NVDR that only receives dividend payout, but cannot vote. 

The brokerage firm gave a “BUY” recommendation on BDMS with a target price at THB34.10 per share.